Alto Neuroscience, Inc.
Public company- Headquarters
- MOUNTAIN VIEW, California
- Ticker
- ANRO
- CIK
- 0001999480
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
1 appointment, 1 departure
Last event
Aug 27, 2026
Executive appointmentPresident and Chief Financial Officer appointed: Nicholas C. Smith
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| President and Chief Financial OfficerNicholas C. Smith | Aug 27, 2026 | Appointed |
| PresidentAmit Etkin, M.D., Ph.D. | Aug 27, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
No events of this type on record.
Show all eventsLast verified Nov 8, 2026